相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials
Virginie Dufrost et al.
AUTOIMMUNITY REVIEWS (2021)
Heavy menstrual bleeding in women on oral anticoagulants
Bethany T. Samuelson Bannow et al.
THROMBOSIS RESEARCH (2021)
Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis
Vasyl Katerenchuk et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study
K. Malec et al.
LUPUS (2020)
Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban
Romain Stammler et al.
LUPUS (2020)
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis
Maha A. T. Elsebaie et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis
Jorge Sanchez-Redondo et al.
CLINICAL THERAPEUTICS (2019)
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial
Josep Ordi-Ros et al.
ANNALS OF INTERNAL MEDICINE (2019)
Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort study
T. Sato et al.
LUPUS (2019)
CLINICAL PRESENTATION OF PAGET DISEASE OF BONE: IS IT CHANGING? A RETROSPECTIVE ANALYSIS ON 368 PATIENTS
Chiara Crotti et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
Vittorio Pengo et al.
BLOOD (2018)
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
Ida Martinelli et al.
HAEMATOLOGICA (2018)
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
Ida Martinelli et al.
HAEMATOLOGICA (2018)
Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis
Virginie Dufrost et al.
AUTOIMMUNITY REVIEWS (2018)
The role of platelets in antiphospholipid syndrome
G. Baroni et al.
PLATELETS (2017)
Catastrophic antiphospholipid syndrome on switching from warfarin to rivaroxaban
Maeve P. Crowley et al.
THROMBOSIS RESEARCH (2017)
Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses
Abdulaali R. Almutairi et al.
CLINICAL THERAPEUTICS (2017)
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER II, and RE-MEDY™
Samuel Z. Goldhaber et al.
VASCULAR MEDICINE (2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
Hannah Cohen et al.
Lancet Haematology (2016)
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
Daniel Caldeira et al.
HEART (2015)
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
Nico De Crem et al.
THROMBOSIS RESEARCH (2015)
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Agon Mekaj et al.
Therapeutics and Clinical Risk Management (2015)
14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
Doruk Erkan et al.
AUTOIMMUNITY REVIEWS (2014)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman et al.
CIRCULATION (2014)
The impact of dosing frequency on medication adherence in chronic cardiovascular disease: Systematic review and meta-analysis
Daniel Caldeira et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2014)
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Estimated Frequency of Antiphospholipid Antibodies in Patients With Pregnancy Morbidity, Stroke, Myocardial Infarction, and Deep Vein Thrombosis: A Critical Review of the Literature
Laura Andreoli et al.
ARTHRITIS CARE & RESEARCH (2013)
Pros and cons of new oral anticoagulants
Kenneth A. Bauer
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Guidelines on the investigation and management of antiphospholipid syndrome
David Keeling et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome
Zurina Romay-Penabad et al.
BLOOD (2011)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment
A. Tripodi et al.
JOURNAL OF INTERNAL MEDICINE (2011)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome
R Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 -: an oral, direct Factor Xa inhibitor
E Perzborn et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome
R Takeuchi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
